FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

FDA's oversight of the 1982 canned salmon recalls : report to the Chairman, Subcommittee on Oversights and Investigations, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.

"B-210249"--1st prelim. p."GAO/HRD-84-77."Includes bibliographical references."September 12, 1984."C...

Medical devices : FDA review time : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"B-261822"--P. 1."GAO/PEMD-96-2.""October 1995."Cover title.Includes bibliographical references.Mode...

FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies /

United States. General Accounting Office.

January 1988

At head of title : Report to the ranking minority member, Special Committee on Aging, U.S. Senate."B...

Drug safety : improvement needed in FDA's postmarket decision-making and oversight process : report to Congressional requesters.

United States. Government Accountability Office.

"GAO-06-402.""March 2006."Cover title.Includes bibliographical references.Mode of access: Internet

FDA drug approval : review time has decreased in recent years : report to Congressional requesters /

United States. General Accounting Office.

"B-266023"--P. 1."GAO/PEMD-96-1.""October 1995."Cover title.Includes bibliographical references.Mode...

Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.

"B-223076"--P. [1]."GAO/IMTEC-86-32.""September 1986."Distributed to depository libraries in microfi...

Prescription drugs : information on selected drug utilization review systems : report to the Chairman, Special Committee on Aging, U.S. Senate/

United States. General Accounting Office.

January 1989

Running title: Prescription drug utilization review systems."GAO/PEMD-89-18""May 1989."Cover title.M...

Medical devices : FDA's forecasts of problem reports and FTEs under H.R. 4640 : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"B-231242"--p.1."GAO/PEMD-88-30""July 1988"Cover title.Includes bibliographical references.Mode of a...

FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives /

Hamilton, Mary R.
United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.
United States. General Accounting Office.

"For release ... 10:00 a.m. EST Thursday May 2, 1996."Cover title.Includes bibliographical reference...

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

FDA regulations : sustained management attention needed to improve timely issuance : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"GAO/HRD-92-35.""February 1992.""B-246300"--P. 1.Cover title.Mode of access: Internet

FDA resources : comprehensive assessment of staffing, facilities, and equipment needed : report to congressional requesters /

United States. General Accounting Office.

January 1989

"September 1989"Cover title."B-235713"--p.[1]"GAO/HRD-89-142"Mode of access: Internet

Medical devices : FDA's implementation of the medical device reporting regulation : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1989

"B-223710"--p.[1]"GAO/PEMD-89-10""February 1989"Cover title."References": p.83.Mode of access: Inter...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

FDA's oversight of the 1982 canned salmon recalls : report to the Chairman, Subcommittee on Oversights and Investigations, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.

"B-210249"--1st prelim. p."GAO/HRD-84-77."Includes bibliographical references."September 12, 1984."C...

Medical devices : FDA review time : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"B-261822"--P. 1."GAO/PEMD-96-2.""October 1995."Cover title.Includes bibliographical references.Mode...

FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies /

United States. General Accounting Office.

January 1988

At head of title : Report to the ranking minority member, Special Committee on Aging, U.S. Senate."B...

Drug safety : improvement needed in FDA's postmarket decision-making and oversight process : report to Congressional requesters.

United States. Government Accountability Office.

"GAO-06-402.""March 2006."Cover title.Includes bibliographical references.Mode of access: Internet

FDA drug approval : review time has decreased in recent years : report to Congressional requesters /

United States. General Accounting Office.

"B-266023"--P. 1."GAO/PEMD-96-1.""October 1995."Cover title.Includes bibliographical references.Mode...

Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.

"B-223076"--P. [1]."GAO/IMTEC-86-32.""September 1986."Distributed to depository libraries in microfi...

Prescription drugs : information on selected drug utilization review systems : report to the Chairman, Special Committee on Aging, U.S. Senate/

United States. General Accounting Office.

January 1989

Running title: Prescription drug utilization review systems."GAO/PEMD-89-18""May 1989."Cover title.M...

Medical devices : FDA's forecasts of problem reports and FTEs under H.R. 4640 : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"B-231242"--p.1."GAO/PEMD-88-30""July 1988"Cover title.Includes bibliographical references.Mode of a...

FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives /

Hamilton, Mary R.
United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.
United States. General Accounting Office.

"For release ... 10:00 a.m. EST Thursday May 2, 1996."Cover title.Includes bibliographical reference...

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

FDA regulations : sustained management attention needed to improve timely issuance : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"GAO/HRD-92-35.""February 1992.""B-246300"--P. 1.Cover title.Mode of access: Internet

FDA resources : comprehensive assessment of staffing, facilities, and equipment needed : report to congressional requesters /

United States. General Accounting Office.

January 1989

"September 1989"Cover title."B-235713"--p.[1]"GAO/HRD-89-142"Mode of access: Internet

Medical devices : FDA's implementation of the medical device reporting regulation : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1989

"B-223710"--p.[1]"GAO/PEMD-89-10""February 1989"Cover title."References": p.83.Mode of access: Inter...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

FDA's oversight of the 1982 canned salmon recalls : report to the Chairman, Subcommittee on Oversights and Investigations, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.

"B-210249"--1st prelim. p."GAO/HRD-84-77."Includes bibliographical references."September 12, 1984."C...

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

Abstract

Extracted data

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

Abstract

Extracted data

Related items

Related items